Gadopentetate Dimeglumine
Generic Name: gadopentetate dimeglumine
Manufactured by BAYER HLTHCARE. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: GADOPENTETATE DIMEGLUMINE (469.01MG/ML). Application: NDA021037.
Overview
Manufactured by BAYER HLTHCARE. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: GADOPENTETATE DIMEGLUMINE (469.01MG/ML). Application: NDA021037.
Dosage
Available as injectable for injection use.
Related Medications
San-a-gel
san-a-gel
purpose Antiseptic
Necitumumab
necitumumab
Epidermal Growth Factor Receptor Antagonist [EPC]
11 DESCRIPTION Necitumumab is an anti-EGFR recombinant human monoclonal antibody of the IgG1 kappa isotype that specifically binds to the ligand binding site of the human EGFR. Necitumumab has an approximate molecular weight of 144.8 kDa. Necitumumab is produced in genetically engineered mammalian NS0 cells. PORTRAZZA is a sterile, preservative free, clear to slightly opalescent and colorless to slightly yellow solution.
Ranolazine
ranolazine
Anti-anginal [EPC]
11 DESCRIPTION Ranolazine is available as a film-coated, non-scored, extended-release tablet for oral administration. Ranolazine is a racemic mixture, chemically described as 1-piperazineacetamide, N -(2,6- dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, (±)-. It has an empirical formula of C 24 H 33 N 3 O 4 , a molecular weight of 427.54 g/mole, and the following structural formula: Ranolazine is a white to off-white crystalline powder.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.